₹ 14878 / 43 shares
Issue Date
--
Investment/lot
₹ 14878
Price Range
346
Lot Size
43
IPO Size
₹ 840.27 Cr
Listing On
1 Nov'23
Issue Price
--
Listed Price
₹ 380
Retail Gain/Listing Gain
▲9.83%
Blue Jet Healthcare Limited is a specialty pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. The company has manufacturing capabilities in contrast media intermediates and high-intensity sweeteners, including saccharin and its salts.
The company’s operations are primarily organised into three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (APIs).
In the past three Financial Years and the three months ended June 30, 2023, the company invoiced more than 400 customers in 39 countries. They have built a long-term customer base with innovator pharmaceutical companies and multi-national generic pharmaceutical companies, supported by committed multi-year contracts of up to five years.
With that, let's take a look at the competitive strengths and risk factors for Blue Jet Healthcare Limited:
Here are the key financials for Blue Jet Healthcare Limited:
Particulars (in Rs. million)
Particulars (in Rs. million)
How to apply for IPO through ASBA
Kotak Securities
•00m 59s
Blue Jet Healthcare Ltd will list on 2023-11-01.
840.27 is the issue size of Blue Jet Healthcare Ltd IPO.
The minimum lot size is 43 shares and the investment required is ₹14878.
The price band of Blue Jet Healthcare Ltd IPO is ₹346 to ₹0.
You can read more about Blue Jet Healthcare Ltd and its IPO from the company’s red herring prospectus (RHP) here.
The Blue Jet Healthcare Limited IPO has an issue size of Rs. 840.27 crores. The IPO opens for subscription on 25th October and closes on 27th October 2023.
Link Intime India Private Limited is the registrar for this IPO.
You may read more about Blue Jet Healthcare Limited and its IPO from the company’s red herring prospectus (RHP) here: